The negative effect of GM3 was first demonstrated for EGFR signaling in a variety of cell lines including hepatoma, hepatocellular carcinoma and neuroblastoma cells [121,122,123,124]. This evidence concerns the gene EGFR and hepatocellular carcinoma.